시장보고서
상품코드
1758068

세계의 심장 수복 시스템 시장

Cardiac Restoration Systems

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 270 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심장 수복 시스템 시장은 2030년까지 7억 5,990만 달러에 달할 전망

2024년에 6억 70만 달러로 추정되는 세계의 심장 수복 시스템 시장은 2030년에는 7억 5,990만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 4.0%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 승모판 수복 시스템은 CAGR 3.2%를 기록하며, 분석 기간 종료시에는 4억 5,860만 달러에 달할 것으로 예측됩니다. 좌심실 수복 시스템 부문의 성장률은 분석 기간에 CAGR 5.3%로 추정됩니다.

미국 시장은 1억 6,370만 달러로 추정, 중국은 CAGR 7.2%로 성장 예측

미국의 심장 수복 시스템 시장은 2024년에 1억 6,370만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 1억 5,310만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 7.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.7%와 3.1%로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%로 성장할 것으로 예측됩니다.

세계의 심장 수복 시스템 시장 - 주요 동향과 촉진요인 정리

심장 수복 시스템이 첨단 심부전 치료의 핵심으로 부상하는 이유는 무엇인가?

심장 수복 시스템은 심부전 및 관련 심장 구조적 질환을 앓고 있는 환자들을 위한 혁신적인 수명 연장 솔루션으로 큰 호응을 얻고 있습니다. 이 시스템은 기능 장애가 있는 심장, 특히 좌심실의 모양을 만들고, 지지하고, 보강하여 정상적인 모양을 되찾고, 기능을 개선하고, 울혈성심부전에 수반되는 증상을 완화하도록 설계되었습니다. 심혈관계 질환은 여전히 전 세계 사망원인 1위이며, 수백만 명의 사람들이 만성 심부전으로 고통받고 있으며, 약물요법이나 침습적인 이식수술에 대한 대안이 시급히 요구되고 있습니다. 심장 기능 회복은 내과적 치료와 심실보조장치(VAD)(VAD) 또는 심장 이식 같은 보다 적극적인 치료의 가교 역할을 하며, 이러한 치료가 적합하지 않은 환자들에게 특히 가치가 있습니다. 심외막 임플란트, 심실 리모델링 장비, 주사 가능한 바이오스카폴드와 같은 시스템은 심장의 자연적인 해부학적 구조를 크게 손상시키지 않고 심장의 기계적 효율을 회복시킵니다. 심장 마비 후 생존율이 향상됨에 따라 더 많은 환자들이 심장 손상의 장기적인 영향과 함께 살아가고 있으며, 이에 따라 회복적 접근 방식에 대한 수요가 증가하고 있습니다. 또한 조기 진단의 개선, 심장병에 대한 인식의 향상, 신흥 국가에서의 심장 치료 접근성 향상으로 인해 이러한 치료법의 대상이 되는 환자층이 확대되고 있습니다. 심장 수복 시스템은 현재 심장 박출량을 개선할 뿐만 아니라 환자의 삶의 질과 기능적 독립성을 향상시키고 궁극적으로 의료 이용률과 입원 비용을 절감할 수 있는 장기적인 솔루션으로 간주되고 있습니다.

기술 혁신은 어떻게 심장 수복 장비의 성능과 적응성을 향상시키고 있는가?

기술 혁신은 심장 수복 시스템의 기능과 정밀도를 확장하고, 더 안전하고, 더 효과적이며, 더 광범위한 환자의 해부학적 구조와 질병 진행에 적응할 수 있도록 하는 데 있으며, 혁신적인 역할을 하고 있습니다. 재료 과학의 발달로 심장 조직의 역학을 모방한 생체 적합성과 유연성이 뛰어난 임플란트 재료가 개발되어 합병증의 위험을 줄이고 심근과의 통합을 촉진했습니다. 소형화와 경카테터 시스템 및 영상 유도 내비게이션과 같은 전달 툴의 도입으로 이러한 장비의 최소 침습적 배치가 가능해져 외과적 외상 및 회복 시간이 크게 단축되었습니다. 일부 최신 시스템은 3D 프린팅과 환자별 모델링을 통해 환자별 심실 구조에 따라 임플란트를 맞춤화하여 치료 결과를 개선할 수 있습니다. 또한 생체흡수성 스캐폴드 및 주입 가능한 하이드로겔이 개발되어 점차 분해되면서 조직 재생을 촉진하고, 제거할 필요 없이 수복된 심장 환경을 남길 수 있습니다. 실시간 영상 기술 및 수술 중 모니터링 기술과의 통합을 통해 정확한 장비 배치와 기능 최적화를 보장합니다. 또한 수복 시스템에 내장된 스마트 소재와 바이오센서는 장비의 성능, 압력 구배, 심장 기능에 대한 피드백을 조기에 제공함으로써 데이터베이스 맞춤형 치료의 시대를 열어가고 있습니다. 이러한 기술 혁신은 심장 수복 시스템의 치료 가능성을 높일 뿐만 아니라, 조기 구조적 악화 및 동반 질환을 가진 심부전 환자를 포함하여 보다 광범위한 심부전 환자에게 적용 범위를 넓혀가고 있습니다. 기술이 계속 발전함에 따라 심장 재건술은 현대 심부전 관리의 표준적인 요소로 자리 잡고 있습니다.

심장 수복 시스템 수요를 형성하는 헬스케어 동향과 임상 관행은 무엇인가?

의료 서비스 제공, 임상 가이드라인, 환자 기대치의 변화는 전 세계 순환기 네트워크의 심장 수복 시스템 도입에 큰 영향을 미치고 있습니다. 맞춤형 의료와 정밀의료에 대한 관심이 높아지면서 임상의들은 단순히 증상을 관리하는 것이 아니라 심부전의 근본적인 기계적 원인을 다루는 치료법을 점점 더 많이 찾고 있습니다. 심장 수복 시스템은 수축기 심부전의 주요 심장 기능 저하의 원인인 심실 확장, 벽 박리, 수축력 저하를 표적으로 삼음으로써 이러한 요구를 충족시킬 수 있습니다. 순환기 전문의, 외과 의사, 전기 생리학자로 구성된 다학제 심장 치료 팀 증가는 이러한 시스템을 보다 광범위하게 평가하고 표준 치료 프로토콜에 통합하는 것을 용이하게 하고 있습니다. 또한 심부전이 즉각적인 말기 진단이 아닌 만성적이고 관리 가능한 상태가 됨에 따라 환자의 독립성을 유지하고 반복적인 입원이나 복잡한 장비 치료에 대한 의존도를 줄이기 위해 심장 수복술과 같은 장기적인 솔루션의 중요성이 커지고 있습니다. 보험 상환 프레임워크는 재입원 감소, 심장 이식 필요성의 지연 또는 회피 등 이러한 시스템의 비용 절감 가능성을 인정하는 방향으로 진화하고 있습니다. 또한 더 나은 교육, 동료 옹호, 환자를 새로운 치료 옵션로 연결해주는 디지털 헬스 플랫폼을 통해 새로운 치료법에 대한 환자들의 인식과 의지가 높아지고 있습니다. 심장 수복 장비의 안전성과 유효성을 지원하는 임상시험 데이터는 더욱 견고해지고 있으며, 의사들이 치료 경로의 초기 단계에서 이러한 접근법을 채택하도록 장려하고 있습니다. 헬스케어가 보다 적극적이고 결과 지향적인 모델로 전환함에 따라 구조적 교정 및 기능 회복을 제공하는 심장 수복 시스템과 같은 치료적 개입에 대한 수요는 계속 가속화될 것으로 보입니다.

심장 수복 시스템 세계 시장 성장의 원동력은?

심장 수복 시스템 시장의 성장은 심부전 유병률 증가, 기술 발전, 좋은 임상 결과, 가치 기반 치료를 향한 전략적 추진 등 여러 가지 요인이 복합적으로 작용하여 이루어지고 있습니다. 전 세계에서 인구 고령화와 심근경색 후 생존율 증가로 인해 만성 심기능 장애를 가진 환자가 증가하고 있습니다. 이러한 환자군의 확대는 완전한 외과적 치환술이나 기계적 순환 보조술과 같은 위험이나 제한 없이 심장 기능을 눈에 띄게 개선할 수 있는 중범위 중재술에 대한 수요를 불러일으키고 있습니다. 기술적 측면에서 볼 때, 영상 처리, 재료 과학, 기기 소형화 등의 기술 혁신은 심장 수복 시스템을 보다 쉽게 접근하고 배포할 수 있게 함으로써 학술 및 지역 의료 환경에서 보다 광범위하게 채택될 수 있도록 하고 있습니다. 우수한 임상시험 데이터와 박출률, 운동 능력, 증상 완화를 입증하는 실제 증거는 이러한 장비 시장 잠재력을 더욱 입증하고 있습니다. 또한 규제 당국의 경로가 더욱 간소화되고 있으며, 일부 기기는 FDA와 같은 기관으로부터 CE 마크 승인 및 패스트 트랙 지정을 받아 빠른 시장 진입과 보급을 촉진하고 있습니다. 재정적 측면에서 의료 시스템은 병원 재입원을 줄이고, 만성질환을 적극적으로 관리하고, 총 의료비용을 낮추기 위한 인센티브를 점점 더 강화하고 있습니다. 의료기기 기업, 학술기관, 병원 네트워크 간의 전략적 협력 관계도 기술 혁신과 시장 침투에 박차를 가하고 있습니다. 이러한 역동성을 종합하면 지속가능한 성장을 위한 탄탄한 기반이 형성되고 있으며, 심장 수복 시스템은 진화하는 심부전 치료의 전망에서 중요한 혁신으로 자리매김하고 있습니다.

부문

제품(승모판 수복 시스템, 좌심실 수복 시스템); 최종 사용(병원 최종 사용, 외래 수술 센터 최종 사용, 기타 최종 사용)

조사 대상 기업의 예

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI 통합

우리는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 도메인 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.15

Global Cardiac Restoration Systems Market to Reach US$759.9 Million by 2030

The global market for Cardiac Restoration Systems estimated at US$600.7 Million in the year 2024, is expected to reach US$759.9 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Mitral Valve Restoration Systems, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$458.6 Million by the end of the analysis period. Growth in the Left Ventricular Restoration Systems segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$163.7 Million While China is Forecast to Grow at 7.2% CAGR

The Cardiac Restoration Systems market in the U.S. is estimated at US$163.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$153.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Cardiac Restoration Systems Market - Key Trends & Drivers Summarized

Why Are Cardiac Restoration Systems Emerging as a Cornerstone in Advanced Heart Failure Treatment?

Cardiac restoration systems are gaining significant traction as innovative, life-extending solutions for patients suffering from heart failure and related structural heart conditions. These systems are designed to reshape, support, or reinforce the failing heart-particularly the left ventricle-to restore normal geometry, improve function, and reduce symptoms associated with congestive heart failure. As cardiovascular disease remains the leading cause of death globally, with millions affected by chronic heart failure, there is an urgent demand for therapeutic alternatives beyond pharmacological treatment and invasive transplant procedures. Cardiac restoration offers a bridge between medical management and more aggressive interventions like ventricular assist devices (VADs) or heart transplantation, making it particularly valuable for patients who are not suitable candidates for such procedures. Systems such as epicardial implants, ventricular remodeling devices, and injectable bio-scaffolds work to restore the mechanical efficiency of the heart without significantly compromising its natural anatomy. As survival rates post-heart attack improve, more patients are living with the long-term consequences of cardiac damage, driving demand for restorative approaches. Furthermore, improvements in early diagnosis, increased awareness of heart disease, and better access to cardiac care in emerging economies are broadening the patient pool eligible for these interventions. Cardiac restoration systems are now viewed as a viable long-term solution that not only improves cardiac output but also enhances patients' quality of life and functional independence, ultimately reducing healthcare utilization and hospitalization costs.

How Are Technological Innovations Enhancing the Performance and Adaptability of Cardiac Restoration Devices?

Technological innovation is playing a transformative role in expanding the capabilities and precision of cardiac restoration systems, making them safer, more effective, and increasingly adaptable to a wider range of patient anatomies and disease progressions. Advances in material science have led to the development of biocompatible and flexible implant materials that mimic cardiac tissue mechanics, reducing the risk of complications and enhancing integration with the myocardium. Miniaturization and the incorporation of delivery tools like transcatheter systems and image-guided navigation have enabled less invasive deployment of these devices, significantly reducing surgical trauma and recovery times. Some of the latest systems use 3D printing and patient-specific modeling to customize implants based on a patient’s unique ventricular structure, improving therapeutic outcomes. Furthermore, bioresorbable scaffolds and injectable hydrogels are being developed to promote tissue regeneration while gradually degrading, leaving behind a restored cardiac environment without the need for removal. Integration with real-time imaging and intraoperative monitoring technologies ensures precise device placement and function optimization. Additionally, smart materials and biosensors embedded in restoration systems are providing early feedback on device performance, pressure gradients, and cardiac function, ushering in the era of data-driven, personalized therapy. These innovations are not only enhancing the therapeutic potential of cardiac restoration systems but are also expanding their applicability across a broader spectrum of heart failure patients, including those with early-stage structural deterioration or coexisting comorbidities. As technology continues to evolve, cardiac restoration is poised to become a standard component of modern heart failure management.

What Healthcare Trends and Clinical Practices Are Shaping the Demand for Cardiac Restoration Systems?

Shifts in healthcare delivery, clinical guidelines, and patient expectations are significantly influencing the adoption of cardiac restoration systems across global cardiology networks. With the growing emphasis on personalized and precision medicine, clinicians are increasingly looking for treatment modalities that address the root mechanical causes of heart failure rather than simply managing symptoms. Cardiac restoration systems fulfill this demand by targeting ventricular dilation, wall thinning, and impaired contractility, which are key contributors to declining heart function in systolic heart failure. The rise in multidisciplinary heart teams, composed of cardiologists, surgeons, and electrophysiologists, is also facilitating broader evaluation and integration of these systems into standard care protocols. Furthermore, as heart failure becomes a chronic, manageable condition rather than an immediate terminal diagnosis, long-term solutions like cardiac restoration are gaining importance for maintaining patient independence and reducing reliance on repeated hospitalizations or complex device therapy. Reimbursement frameworks are evolving to recognize the cost-saving potential of these systems, particularly in reducing readmissions and delaying or avoiding the need for heart transplants. Patient awareness and willingness to pursue novel therapies have also increased, driven by better education, peer advocacy, and digital health platforms that connect patients to emerging treatment options. Clinical trial data supporting the safety and efficacy of cardiac restoration devices is becoming more robust, encouraging physicians to adopt these approaches earlier in the treatment pathway. As healthcare moves toward more proactive, outcome-oriented models, the demand for therapeutic interventions like cardiac restoration systems that offer structural correction and functional recovery will continue to accelerate.

What’s Driving the Growth of the Global Cardiac Restoration Systems Market?

The growth in the cardiac restoration systems market is driven by several intersecting factors, including the rising prevalence of heart failure, technological advancements, favorable clinical outcomes, and the strategic push toward value-based care. Globally, aging populations and increased survival rates following myocardial infarction are contributing to a larger patient base living with chronic cardiac dysfunction. This expanding population fuels the demand for mid-range interventions that offer tangible improvements in heart function without the risks or limitations of full surgical replacement or mechanical circulatory support. From a technological perspective, innovations in imaging, material science, and device miniaturization are making cardiac restoration systems more accessible and easier to deploy, allowing for broader adoption in both academic and community healthcare settings. Positive clinical trial data and real-world evidence demonstrating improvements in ejection fraction, exercise capacity, and symptom relief are further validating the market potential of these devices. Additionally, regulatory pathways are becoming more streamlined, with several devices gaining CE Mark approval or fast-track designations from agencies like the FDA, facilitating quicker market entry and adoption. On the financial front, healthcare systems are increasingly incentivized to reduce hospital readmissions, manage chronic conditions proactively, and lower the total cost of care-goals that align well with the function and promise of cardiac restoration therapy. Strategic collaborations between medical device companies, academic institutions, and hospital networks are also fueling innovation and market penetration. Altogether, these dynamics are creating a robust foundation for sustained growth, positioning cardiac restoration systems as a critical innovation in the evolving landscape of heart failure treatment.

SCOPE OF STUDY:

The report analyzes the Cardiac Restoration Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Mitral Valve Restoration Systems, Left Ventricular Restoration Systems); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Restoration Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Throws the Spotlight on Cardiac Restoration as a Transformative Therapy Option
    • Limitations of Conventional Treatments Accelerate Demand for Minimally Invasive Cardiac Restoration Systems
    • Expansion of Structural Heart Disease Programs Strengthens the Business Case for Ventricular Restoration Technologies
    • Aging Population and Higher Heart Disease Risk Profiles Sustain Long-Term Need for Cardiac Repair Solutions
    • Breakthroughs in Device-Based Therapies Propel Growth in Left Ventricular Restoration System Adoption
    • Patient Preference for Minimally Invasive Options Drives Adoption of Transcatheter-Based Restoration Platforms
    • Increased Clinical Trials and Real-World Data Enhance Confidence in Efficacy of Cardiac Restoration Devices
    • Hospital Focus on Readmission Reduction and Functional Improvement Supports Integration into Heart Failure Care Pathways
    • Rising Use of Cardiac MRI and Advanced Imaging Fuels Personalized Planning for Restoration Procedures
    • Surge in Advanced Heart Failure Referrals Spurs Market Demand for Bridge-to-Recovery Solutions
    • Integration with Digital Health Tools and Remote Monitoring Strengthens Post-Procedure Outcome Tracking
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Restoration Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Mitral Valve Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Left Ventricular Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제